Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03134417 · ClinicalTrials.gov registry record · NA
Magnesium and Vitamin D Supplementation and Cardiometabolic Outcomes
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
NCT03134417 is a NA study that has completed, run by Drexel University. The registered enrollment target is 109 participants.
The verdict
NCT03134417, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of a combined vitamin D and magnesium supplementation on parathyroid hormone and cardiometabolic health in persons living with obesity.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Vitamin D
- DIETARY_SUPPLEMENT Vitamin D and magnesium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2016-02-01 |
| Est. Completion | 2021-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03134417
The ClinicalTrials.gov registry entry for NCT03134417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03134417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03134417 about?
NCT03134417 is a clinical study titled "Magnesium and Vitamin D Supplementation and Cardiometabolic Outcomes". The purpose of this study is to investigate the effects of a combined vitamin D and magnesium supplementation on parathyroid hormone and cardiometabolic health in persons living with obesity.
What is the current status of trial NCT03134417?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2016-02-01. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT03134417?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin D (DIETARY_SUPPLEMENT), Vitamin D and magnesium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03134417?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.